Literature DB >> 17918192

Loss of the eukaryotic initiation factor 3f in pancreatic cancer.

Adriana Doldan1, Anupama Chandramouli, Reneé Shanas, Achyut Bhattacharyya, John T Cunningham, Mark A Nelson, Jiaqi Shi.   

Abstract

Aberrant regulation of the translation initiation is known to contribute to tumorigenesis. eIF3 plays an important role in translation initiation. eIF3f is the p47 subunit of the eIF3 complex whose function in cancer is not clear. Initial studies from our group indicated that eIF3f expression is decreased in pancreatic cancer. Overexpression of eIF3f induces apoptosis in pancreatic cancer cells. The eIF3f gene is located at chromosome band region 11p15.4. Loss of 11p15.4 is a common event in many tumors including pancreatic cancer. In order to investigate the molecular mechanism of the decreased expression of eIF3f in pancreatic cancer, we performed loss of heterozygosity (LOH) analysis in 32 pancreatic cancer specimens using three microsatellite markers encompassing the eIF3f gene. We showed that the prevalence of LOH ranged from 71% to 93%. We also performed eIF3f gene copy number analysis using quantitative real time PCR to further confirm the specific allelic loss of eIF3f gene in pancreatic cancer. We demonstrated a statistically significant decrease of eIF3f gene copy number in pancreatic tumors compared with normal tissues with a tumor/normal ratio of 0.24. Furthermore, RNA in situ hybridization and tissue microarray immunohistochemistry analysis demonstrated that eIF3f expression is significantly decreased in human pancreatic adenocarcinoma tissues compared to normal pancreatic tissues. These data provides new insight into the understanding of the molecular pathogenesis of eIF3f during pancreatic tumorigenesis. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17918192      PMCID: PMC2568992          DOI: 10.1002/mc.20379

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  42 in total

1.  High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.

Authors:  G Rigaud; E Missiaglia; P S Moore; G Zamboni; M Falconi; G Talamini; A Pesci; A Baron; D Lissandrini; G Rindi; P Grigolato; P Pederzoli; A Scarpa
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

2.  Functional analysis of human ornithine decarboxylase alleles.

Authors:  Y Guo; R B Harris; D Rosson; D Boorman; T G O'Brien
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

3.  Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11.

Authors:  J C Fournet; C Mayaud; P de Lonlay; M S Gross-Morand; V Verkarre; M Castanet; M Devillers; J Rahier; F Brunelle; J J Robert; C Nihoul-Fékété; J M Saudubray; C Junien
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 4.  Selected features of nonendocrine pancreatic cancer.

Authors:  K M Anderson; J E Harris
Journal:  Exp Biol Med (Maywood)       Date:  2001-06

5.  Loss of heterozygosity in childhood de novo acute myelogenous leukemia.

Authors:  D A Sweetser; C S Chen; A A Blomberg; D A Flowers; P C Galipeau; M T Barrett; N A Heerema; J Buckley; W G Woods; I D Bernstein; B J Reid
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

6.  Reduced expression of INT-6/eIF3-p48 in human tumors.

Authors:  A Marchetti; F Buttitta; S Pellegrini; G Bertacca; R Callahan
Journal:  Int J Oncol       Date:  2001-01       Impact factor: 5.650

7.  Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas.

Authors:  M Rothe; Y Ko; P Albers; N Wernert
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

8.  Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.

Authors:  Susan C Abraham; Tsung-Teh Wu; Ralph H Hruban; Jae-Hyuk Lee; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; David S Klimstra
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

9.  Molecular interaction between human tumor marker protein p150, the largest subunit of eIF3, and intermediate filament protein K7.

Authors:  L Lin; T Holbro; G Alonso; D Gerosa; M M Burger
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

10.  Identification of a 170-kDa protein over-expressed in lung cancers.

Authors:  R Pincheira; Q Chen; J T Zhang
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

View more
  31 in total

1.  Inhibition of HIV-1 replication by eIF3f.

Authors:  Susana T Valente; Greg M Gilmartin; Christina Mott; Brie Falkard; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

2.  Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her-2/neu Expression in Gastric Cancer.

Authors:  Yu Cheng; Jin Zhou; Honglun Li
Journal:  Clin Transl Sci       Date:  2015-02-14       Impact factor: 4.689

Review 3.  eIF3: a factor for human health and disease.

Authors:  Andreia Gomes-Duarte; Rafaela Lacerda; Juliane Menezes; Luísa Romão
Journal:  RNA Biol       Date:  2017-11-13       Impact factor: 4.652

Review 4.  Translational control in cancer etiology.

Authors:  Davide Ruggero
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

5.  Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma.

Authors:  Fushi Wen; Alex Shen; Reneé Shanas; Achyut Bhattacharyya; Fangru Lian; Galen Hostetter; Jiaqi Shi
Journal:  Ann Surg Oncol       Date:  2010-05-25       Impact factor: 5.344

6.  MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers.

Authors:  Anupama Chandramouli; Benjamin Chidi Onyeagucha; Melania E Mercado-Pimentel; Lenka Stankova; Nisreen Abu Shahin; Bonnie J LaFleur; Ronald L Heimark; Achyut K Bhattacharyya; Mark A Nelson
Journal:  Cancer Biol Ther       Date:  2012-02-01       Impact factor: 4.742

7.  Loss of the eukaryotic initiation factor 3f in melanoma.

Authors:  Adriana Doldan; Anupama Chandramouli; Reneé Shanas; Achyut Bhattacharyya; Stanley P L Leong; Mark A Nelson; Jiaqi Shi
Journal:  Mol Carcinog       Date:  2008-10       Impact factor: 4.784

8.  Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.

Authors:  Renyuan Zhou; Reneé Shanas; Mark A Nelson; Achyut Bhattacharyya; Jiaqi Shi
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

9.  Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis.

Authors:  Jiaqi Shi; John W B Hershey; Mark A Nelson
Journal:  FEBS Lett       Date:  2009-02-24       Impact factor: 4.124

Review 10.  Pathology and molecular genetics of pancreatic neoplasms.

Authors:  Laura D Wood; Ralph H Hruban
Journal:  Cancer J       Date:  2012 Nov-Dec       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.